Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in INMB — Inmune Bio, Inc.

CIK 886982 NEW YORK, NY
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$301,948
+$40,256 QoQ
Shares Held
185,245
-20.0% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 83 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. INMB ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in INMB

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $301,948 185,245
2026-03-31 $261,692 231,586
2025-12-31 $88,103 56,477
2025-09-30 $31,679 15,304
2025-06-30 $54,510 23,598
2025-03-31 $317,991 40,716
2024-12-31 $297,081 63,615
2024-09-30 $177,918 33,009
2024-06-30 $102,814 11,657
2024-03-31 $1,029,358 87,605
2021-12-31 $204,540 20,053